A method of treating resistant non-Hodgkin lymphoma, medulloblastoma, and/or ALK+ non-small cell lung cancer in a mammal by administering a solid dispersion comprising an amorphous thienotriazolodiazepine compound of the Formula (1) wherein R′ is alkyl having a carbon number of 1-4, R2 is a hydrogen atom; a halogen atom; or alkyl having a carbon number of 1-4 optionally substituted by a halogen atom or a hydroxyl group, R3 is a halogen atom; phenyl optionally substituted by a halogen atom, alkyl having a carbon number of 1-4, alkoxy having a carbon number of 1-4 or cyano; —NR 5-{CH 2)m-, —R6 wherein R5 is a hydrogen atom or alkyl having a carbon number of 1-4, m is an integer of 0-4, and R6 is phenyl or pyridyl optionally substituted by a halogen atom.
展开▼
机译:通过给予包含式(1)的无定形硫杂三氮杂二氮杂卓化合物的固体分散体来治疗哺乳动物中的耐药性非霍奇金淋巴瘤,髓母细胞瘤和/或ALK +非小细胞肺癌的方法,其中R'是具有碳数的烷基在1-4中,R 2是氢原子;卤素原子; R 3为卤素原子;或碳原子数为1〜4的烷基,可任选地被卤素原子或羟基取代。任选地被卤素原子取代的苯基,碳数为1-4的烷基,碳数为1-4的烷氧基或氰基; -NR 5- {CH 2)m-,-R6其中R5是氢原子或碳数为1-4的烷基,m是0-4的整数,并且R6是任选地被卤素取代的苯基或吡啶基原子。
展开▼